What is Joylux?
Joylux specializes in innovative women's intimate wellness products designed for home use, focusing on enhancing comfort and confidence during menopause. Their offerings include hormone-free red-light devices and intimate care solutions that address issues such as dryness and low libido. The company targets women navigating menopause, providing tools and resources to support their intimate health journey. Founded by Colette Courtion, Joylux aims to empower women with effective, doctor-trusted products and educational support. By bridging the gap between clinical-grade technology and consumer accessibility, Joylux has established itself as a key player in the femtech industry, effectively disrupting traditional approaches to intimate health management.
How much funding has Joylux raised?
Joylux has raised a total of $24.9M across 5 funding rounds:
Private Equity
$3.8M
Angel/Seed
$3M
Series A
$5M
Debt
$150K
Series A
$13M
Private Equity (2015): $3.8M with participation from vSculpt
Angel/Seed (2015): $3M, investors not publicly disclosed
Series A (2018): $5M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Series A (2022): $13M backed by J Ventures International
Key Investors in Joylux
vSculpt
A specialized entity focused on the development and distribution of intimate wellness technology, providing the foundational hardware for Joylux's product suite.
J Ventures International
A strategic investment firm with a diverse portfolio, providing the necessary capital to support Joylux's recent enterprise-level scaling initiatives.
Undisclosed Investor
An undisclosed investor participating in the funding round to support the company's long-term growth and market expansion.
What's next for Joylux?
With the recent influx of capital, Joylux is poised to enter a new phase of enterprise-level expansion. The strategic focus will likely center on scaling its product distribution channels and deepening its research and development efforts to introduce next-generation wellness devices. As the company navigates this growth stage, it will prioritize market penetration and the enhancement of its digital health ecosystem. By maintaining its focus on evidence-based, hormone-free solutions, Joylux is well-positioned to capture a larger share of the growing menopause wellness market, ultimately driving long-term value for stakeholders and improving health outcomes for its target demographic.
See full Joylux company page
